News & Press Releases

Access the latest news about Lipidor, our current projects, publications and collaborations. Thank you for your interest in Lipidor!

Subscribe

December 3, 2024

Lipidor presents Nomination Committee

STOCKHOLM, Sweden, 3rd December 2024 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today presents its Nomination Committee, which shall have four members, in accordance with the applicable instructions resolved by the Annual General Meeting 2020. The three largest shareholders who are registered with Euroclear Sweden AB on…

May 9, 2023

NOTICE OF ANNUAL GENERAL MEETING IN LIPIDOR AB (PUBL)

NOTE: This is an unofficial translation of the original Swedish notice. In case of discrepancies, the Swedish version shall prevail. The shareholders…

April 26, 2023

Lipidor AB (publ) publishes annual report for 2022

STOCKHOLM, Sweden, 26th April 2023 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its annual report for the…

February 22, 2023

Lipidor AB (publ) publishes year-end report for 2022

STOCKHOLM, Sweden, 22 February 2023 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its year-end report for the…

January 17, 2023

Bulletin from the extraordinary general meeting of Lipidor AB (publ)

Lipidor AB (publ) (“Lipidor” or the “Company”) held an extraordinary general meeting (the “EGM”) on 17 January 2023 in Stockholm. The EGM…

December 23, 2022

NOTICE OF EXTRAORDINARY GENERAL MEETING IN LIPIDOR AB (PUBL)

The shareholders of Lipidor AB (publ) reg. no. 556779-7500 (“Lipidor” or the “Company”) are hereby given notice to attend the Extraordinary General…

December 23, 2022

The Board of Lipidor resolves to summon an Extraordinary General Meeting for approval of the sale of subsidiary shares to major owners

STOCKHOLM, 23 December 2022 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI), (“Lipidor” or the “Company”) today announces that the…

December 14, 2022

Lipidor secures bridge financing of at least SEK 5 million through loans and subsidiary share sales, and takes cost-saving measures including staff layoffs

STOCKHOLM, Sweden, 14th December 2022 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI), (“Lipidor” or the “Company”) today announces that…

December 8, 2022

Lipidor presents Nomination Committee

STOCKHOLM, Sweden, 8 December 2022 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today presents its Nomination Committee, which shall…

November 23, 2022

Lipidor AB (publ) publishes interim report for third quarter 2022

STOCKHOLM, Sweden, 23 November 2022 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the…

November 15, 2022

Lipidor provides update following outcome of Phase III study of psoriasis candidate AKP02

STOCKHOLM, 15 November 2022 – On October 28, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announced that the Phase III…